2026 NPPES data Oral and Maxillofacial Pathology Dentistry NPI 1972505493 DMD
Verify on CMS →

ROBERT KELSCH, DMD

Oral and Maxillofacial Pathology Dentistry in NEW HYDE PARK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
814
Medicare Part D claims · 196 beneficiaries · Oral and Maxillofacial Pathology Dentistry avg: 303
MIPS score
100/100
▲ 17 pts above national avg 83.1 · [object Object]
What the federal data reveals: ROBERT KELSCH, DMD is a Oral and Maxillofacial Pathology Dentistry ([object Object]) practicing in NEW HYDE PARK, New York with a Medicare Part D prescribing footprint of 814 claims across 196 beneficiaries . Their CMS MIPS Final Score of 100/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities .

What stands out: ROBERT KELSCH, DMD reported a CMS MIPS final score of 100 out of 100, above the 83.1 national average, and filed 814 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

ROBERT KELSCH, DMD at a glance

High performer (top quartile)

NPI registry status

Active

Issued 08/15/2005

NPI 1972505493

Primary specialty

Oral and Maxillofacial Pathology Dentistry

Niche

690 US NPIs in this specialty

Medicare Part D claims

814 169% vs specialty avg

2023 prescription claims

Specialty avg: 303

MIPS final score

100/100 16.900000000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in New York

How Oral and Maxillofacial Pathology Dentistry compares to other specialties among New York providers

New York providers

Oral and Maxillofacial Pathology Dentistry share within New York

1. Oral and Maxillofacial Pathology Dentistry42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Oral and Maxillofacial Pathology Dentistry share within New York

Medicare quality performance — MIPS

ROBERT KELSCH, DMD's 2023 MIPS final score plotted against the Oral and Maxillofacial Pathology Dentistry national average

High performer (top quartile)
MIPS Final Score
100/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Oral and Maxillofacial Pathology Dentistry) — 100/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Oral and Maxillofacial Pathology Dentistry) — 100/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ROBERT KELSCH, DMD is a Oral and Maxillofacial Pathology Dentistry provider practicing in NEW HYDE PARK, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: DMD. NPI: 1972505493. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ROBERT KELSCH, DMD appears in the CMS NPPES registry as a Oral and Maxillofacial Pathology Dentistry provider holding DMD credentials at 27005 76TH AVE, NEW HYDE PARK, NY, 11040, with a listed phone of (718) 470-7120. NPI 1972505493 was issued on 08/15/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KELSCH most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 814 prescription claims written by this provider, covering 196 Medicare beneficiaries and totaling roughly $54K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year, compared with the national average of 83.1.

Oral and Maxillofacial Pathology Dentistry is a narrow specialty nationwide, with 690 enrolled providers across 48 states and an average of 303 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

27005 76TH AVE
NEW HYDE PARK, NY 11040

Provider Details

NPI 1972505493
Specialty Oral and Maxillofacial Pathology Dentistry
Credentials DMD
Gender Male
NPI Issued 08/15/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

100
Final Score
Avg: 83.1
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where ROBERT KELSCH, DMD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

MONTEFIORE MEDICAL CENTER
★★★☆☆ 3/5
BRONX, NY
Acute Care Hospitals
CMS CCN: 330059
BLACK HALL DENTAL PC
NEW HYDE PARK, NY
WHITE HALL DENTAL, PC
FOREST HILLS, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to ROBERT KELSCH, DMD. To verify ROBERT KELSCH, DMD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

814
Total Claims
$54K
Total Drug Cost
196
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,217
Total Day Supply
32,124
Generic Drug Cost
$50K
Antibiotic Claims
13

Patient Demographics

Average Patient Age
74.2 years
Avg HCC Risk Score
1.02
Gender Split
82% female / 18% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Fluocinonide
238
Doxycycline Hyclate
123
Clobetasol Propionate
83
Fluconazole
62
Chlorhexidine Gluconate
55
Prednisone
54
Nystatin
47
Methylprednisolone
36
Dexamethasone
26
Cevimeline Hcl
16

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Oral and Maxillofacial Pathology Dentistry Overview

How ROBERT KELSCH, DMD fits within the Oral and Maxillofacial Pathology Dentistry landscape nationally.

690
Oral and Maxillofacial Pathology Dentistry Providers in US
48
States with Oral and Maxillofacial Pathology Dentistry
303
Avg Claims per Provider

ROBERT KELSCH, DMD's 814 claims are above the specialty average of 303.

Nearby Oral and Maxillofacial Pathology Dentistry Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as KELSCH.

Compare Oral and Maxillofacial Pathology Dentistry nationally: see state-by-state distribution →

Frequently Asked Questions

What is ROBERT KELSCH, DMD's specialty?
ROBERT KELSCH, DMD specializes in Oral and Maxillofacial Pathology Dentistry and practices in NEW HYDE PARK, New York. Credentials: DMD.
How much does ROBERT KELSCH, DMD prescribe under Medicare Part D?
In 2023, ROBERT KELSCH, DMD wrote 814 Medicare Part D claims totaling $54K in drug costs for 196 beneficiaries.
What is ROBERT KELSCH, DMD's Medicare quality score?
ROBERT KELSCH, DMD has a CMS MIPS Final Score of 100/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ROBERT KELSCH, DMD located?
ROBERT KELSCH, DMD is located at 27005 76TH AVE, NEW HYDE PARK, NY, 11040. Phone: (718) 470-7120.
What is ROBERT KELSCH, DMD's NPI number?
ROBERT KELSCH, DMD's National Provider Identifier (NPI) is 1972505493, issued on 08/15/2005.
How many Oral and Maxillofacial Pathology Dentistry providers are there in the US?
There are 690 Oral and Maxillofacial Pathology Dentistry providers across 48 states in the US. The average Oral and Maxillofacial Pathology Dentistry provider writes 303 Medicare Part D claims per year.
What drugs does ROBERT KELSCH, DMD prescribe most often?
Based on 2023 Medicare Part D data, ROBERT KELSCH, DMD's most frequently prescribed drugs include Fluocinonide, Doxycycline Hyclate, Clobetasol Propionate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ROBERT KELSCH, DMD accept Medicare?
ROBERT KELSCH, DMD appears in CMS Medicare data with 814 Part D claims and 196 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ROBERT KELSCH, DMD's credentials?
ROBERT KELSCH, DMD's NPI is 1972505493 with credentials DMD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology